Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MMM vs MRNA✓SelectedUSD · MRNAMMM vs MRNA performance historyLatest closeAs of-0.44%11/17
Stock and ETF performance explorer

MMM vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+41.2%
MRNA return
-11.9%
Excess return
+53.1%
Maximum drawdown
-48.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-0.4%-3.9%+3.5%-0.3%
7D-4.1%-17.6%+13.5%-3.4%
30D+10.3%-5.1%+15.4%+10.4%
3M+1.2%+220.8%-219.6%-5.2%
6M+25.4%+321.7%-296.3%+13.9%
YTD+15.1%+601.3%-586.2%-1.3%
1Y+11.4%+735.2%-723.8%-6.3%
3Y+143.6%+170.5%-26.9%+116.3%
5Y+41.2%-14.6%+55.8%+28.8%
All+41.2%-11.9%+53.1%+28.8%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling